Growth Metrics

ClearPoint Neuro (CLPT) Profit After Tax Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -12.28%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 99.26%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 4.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 125.69%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -27.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 51.30%
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn -58.51%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -58.51%
Dec 31, 2025 -44.56%
Sep 30, 2025 -18.44%
Jun 30, 2025 -32.42%
Mar 31, 2025 -45.34%
Dec 31, 2024 -16.61%
Sep 30, 2024 -3.43%
Jun 30, 2024 37.49%
Mar 31, 2024 26.08%
Dec 31, 2023 -5.34%
Sep 30, 2023 -26.95%
Jun 30, 2023 -63.89%
Mar 31, 2023 -41.68%
Dec 31, 2022 -5.69%
Sep 30, 2022 4.82%
Jun 30, 2022 -14.96%
Mar 31, 2022 -55.99%
Dec 31, 2021 -162.26%
Sep 30, 2021 -168.19%
Jun 30, 2021 -125.35%
Mar 31, 2021 -23.50%
Dec 31, 2020 3.88%
Sep 30, 2020 -32.15%
Jun 30, 2020 -7.13%
Mar 31, 2020 -68.34%
Dec 31, 2019 -35.14%
Sep 30, 2019 21.36%
Jun 30, 2019 17.38%
Mar 31, 2019 25.61%
Sep 30, 2016 -944.52%
Jun 30, 2016 41.77%
Mar 31, 2016 48.20%
Sep 30, 2015 93.27%
Jun 30, 2015 -92.09%
Mar 31, 2015 -249.99%
Dec 31, 2014 -11.60%
Sep 30, 2014 -14.16%
Jun 30, 2014 -17.84%
Mar 31, 2014 419.32%
Dec 31, 2013 -279.11%
Sep 30, 2013 -15.70%
Jun 30, 2013 -125.33%
Mar 31, 2013 76.29%
Dec 31, 2012 151.62%
Sep 30, 2012 -29.30%
Jun 30, 2012 71.01%
Mar 31, 2012 -54.37%